Eine Frau als Pionierin der Depressionsforschung: Teresa von Ávila

K. Kraetschmer

doi:10.1055/s-0038-1627117

Nervenheilkunde, Table of Contents

Nervenheilkunde 2008; 27(07): 613-616
DOI: 10.1055/s-0038-1627117

Original- und Übersichtsarbeiten - Original and Review Articles

Schattauer GmbH

Eine Frau als Pionierin der Depressionsforschung: Teresa von Ávila

Eine Würdigung zur 425. Wiederkehr ihres TodestagesA woman as a pioneer in research on depression: Saint Theresa of Ávila

K. Kraetschmer

¹Wr. Neustadt, Österreich

› Author Affiliations

Abstract

Zusammenfassung

In diesem Arbeit wird untersucht, welche Rolle der spanischen Autorin Teresa von Ávila in der Geschichte der Depressionsforschung zukommt. Ausgehend von gegenwärtigen Forschungsschwerpunkten werden Originaltexte der Autorin untersucht und ihre Ausführungen zu verschiedenen Aspekten der Depression, vor allem zur Diagnose und Therapie analysiert. Als Ergebnis der Untersuchung wird vorgeschlagen, dass Teresa von Ávila als Diagnostikerin und Therapeutin eine zentrale Rolle in der Geschichte der Depressionsforschung zuzuschreiben ist.

Summary

This article examines which role plays the Spanish writer Saint Theresa of Ávila in the history of research on depression. Based on recent research activities, original manuscripts of the writer are studied and her comments to different aspects of the depression are determined, especially diagnosis and therapy. It is suggested that Saint Theresa of Ávila as diagnostician and therapist, should have a central place in the history of research on depression.

Schlüsselwörter

Teresa von Ávila - Depression - Kloster

Keywords

Teresa von Ávila - depression - monastery

Full Text

References

Literatur
1 Diagnostic and Statistical Manual of Mental Disorders. 4th edn. (revised). Washington, DC: American Psychiatric Association; 2000
2 Stieglitz RD. et al. Bech-Rafaelsen-Melancholie- Skala (BRMS). Göttingen: 1998
3 Yovell Y. The Nosology of Mood Disorders. Poster presented at the 8th International Neuro-Psychoanalysis Congress.; Vienna, Austria: 2007: 1-8.
4 http://www.runder-tisch.net/index.php?art_id=4595. Zugriff am 11.9.2007.
5 http://www.aerztezentrum-breitenlee.at/depressi/on-merkblatt.htm . Zugriff am 11.9. 2007.
6 Harvey A, Rudolph R, Preskorn S. Evidence of the dual mechanisms of action of venlafaxine. Arch Gen Psychiatry 2000; 57 (Suppl. 05) 503-509.
7 Millan M, Lejeune F, Gobert A. Reciprocal autorecetor and heteroreceptor control of serotonergic, dopaminergic and noradrenergic transmission in the frontal cortex: Relevance to the actions of antidepressant agents. Journal of Psychopharmacology 2000; 14: 114-138.
8 Holsboer F. Stress, hypercortisolism and corticosteroid receptors in depression: implications for therapy. J Aff Disord 2001; 62: 77-91.
9 Nestler EJ, Barrot M. DiLeone. Neurobiology of Depression. Neuron 2002; 34: 13-25.
10 Schreiber S, Bleich A, Pick C. Venlafaxine and Mirtazapine: different mechanisms of antidepressant action, common opioid-mediated antinociceptive effects – a possible opioid involvement in severe depression. J Mol Neurosci 2002; 18: 1-2.
11 Kringelbach M, Rolls E. The functional neuroanatomy of the human orbitofrontal cortex: evidence from neuroimaging and neuropsychology. Progress in Neurobiology 2004; 72: 341-372.
12 Seminowicz D. et al. Limbic-frontal circuitry in major depression: a path-modeling metanalysis. NeuroImage 2004; 22: 409-418.
13 Nestler EJ, Carlezon WA. The mesolimbic dopamine reward circuit in depression. Biological Psychiatry 2006; 12: 1151-1160.
14 Berton O, Nestler EJ. New approaches to antidepressant drug discovery: beyond monoamines. Nature Reviews Neuroscience 2006; 6: 137-151.
15 Holtzheimer P, Nemeroff C. Advances in the treatment of depression. NeuroRx 2006; 3: 42-56.
16 Dunlop BW, Nemeroff CB. The role of dopamine in the pathophysiology of depression. Arch Gen Psychiatry 2007; 64: 327-335.
17 Nemeroff CB. The burden of severe depression: A review of diagnostic challenges and treatment alternatives. J Psychiatr Research 2007; 41: 189-206.
18 Terman M. et al. Light therapy for seasonal affective disorder: a review of efficacy. Neuropsychopharmacology 1989; 2: 1-22.
19 Ebmeier KP. Transcranial Magnetic Stimulation in Affective Disorders. Bipolar Disord 2004; 3: 13-16.
20 Martin JL. et al. Trancranial magnetic stimulation for treating depression. Cochrane Database Syst Rev; 2002. ; 2: CD003493).
21 Mayer KC. Alternative Therapie der Depression. http://www.neuro24.de.2002 : 3.
22 Santa Teresa. Obras Completas. Decima edición preparada por Tomas Alvarez. Burgos: Editorial Monte Carmelo; 1998
23 Teresa von Avila. Das Buch meines Lebens. Übers. von U. Dobhan und E. Peeters. Freiburg: Herder; 2001
24 Michalak EE, Yatham LN, Lam RW. The Role of Psychoeducation in the Treatment of Bipolar Disorder: A Clinical Perspective. Bipolar Disord 2004; 3: 5-11.
25 Cassidy F, Ahearn E, Carrol J. Elevated frequency of diabetes mellitus in hospitalized manic-depressive patients. Am J Psychiatry 1999; 156: 1417-1420.
26 Kanner AM, Balabanov A. Depression and Epilepsy. Neurology 2002; 58: 527-539.
27 Reinares M, Vieta E. The Burden on the Family of Bipolar Patients. Bipolar Disord 2004; 3: 17-23.
28 Farinelli M. et al. Post-stroke Depression and the Psychological Distress of the Caregiver in the Practice of Clinical Rehabilitation. Poster presented at the 8th International Neuro-Psychoanalysis Congress. Vienna, Austria: 2007
29 Souvignier B. Die Würde des Leibes. Heil und Heilung bei Teresa von Ávila. Köln: Bühlau; 2001: 146.
30 Frank E. et al. Interpersonal and social rhythm therapy for bipolar disorder: Integrating interpersonal and behavioural approaches. Behav Ther 1994; 17: 143-149.
31 Rea MM. et al. Family focused treatment versus individual treatment for bipolar disorder: results of a randomized clinical trial. J Consult Clin Psychol 2003; 71: 482-492.